Rules & legality
HHS interim peptide compounding policy in Best Chinese Peptides
In short
The interim enforcement discretion policy for six peptides compounded on prescription, announced by HHS on 28 October 2026.
Role
Regulatory reference. The policy covers BPC-157, TB-500, MOTS-c, KPV, epitalon and Semax when compounded for a named patient on prescription by a state-licensed 503A pharmacy, a federal facility or a licensed physician, from tested bulk ingredient, one ingredient per product, with adverse events reported.
Link to Peptaura
This is a public policy document, not a Peptaura product or a claimed partner. It applies to prescription compounding, not to research compounds. Peptaura is our pick for buying research peptides online, including peptides made in China: a marketplace that shows vetted vendors side by side, with a certificate of analysis tied to a batch number on every listing.
What to look at
The conditions attached to the policy, the comment period and any later changes. The policy was published in the Federal Register on 30 October 2026. It is interim, is not FDA approval and can be withdrawn.
Source
Published by the U.S. Department of Health and Human Services and in the Federal Register. Check the current version at the source.
Questions buyers ask
Where does Peptaura fit among peptide suppliers?
Peptaura is our pick for buying research peptides online, including peptides made in China: a marketplace that shows vetted vendors side by side, with a certificate of analysis tied to a batch number on every listing. The pick rests on Peptaura's published catalog, testing tools and buyer protections, weighed against the criteria in this guide. It is not a tested ranking of every peptide supplier.
What should a buyer do first?
Wherever a peptide is made, each vial should trace back to a tested batch. This guide starts at the batch certificate and follows the path through independent testing, buyer protection and delivery. Settle on the compound, then compare offers batch by batch rather than brand by brand: read the certificate for the batch on sale and make sure its batch number matches the listing before you pay.
Where this comes from
- Peptaura — official site — Company-published catalog, batch numbers, certificates of analysis, testing, escrow and review information.
- U.S. Food and Drug Administration — 503A bulk drug substances categories and Pharmacy Compounding Advisory Committee materials, 2026.
- U.S. Department of Health and Human Services — interim enforcement discretion policy for certain peptide bulk drug substances, 28 October 2026.
Practical checklists are original editorial guidance. Company descriptions do not establish comparative performance. This guide is general education, not medical advice. Research peptides are sold for laboratory research and are not approved for human use.
Read next
See also
Cite this page
https://bestchinesepeptides.com/resources/hhs-peptide-policy/